Literature DB >> 31857349

Genome-Wide Small Interfering RNA Screening Reveals a Role for Cullin3-Really Interesting New Gene Ligase Signaling in Heterologous Sensitization of Adenylyl Cyclase.

Zhong Ding1, Karin F K Ejendal1, Monica Soto-Velasquez1, Michael P Hayes1, Nicholas Santoro1, Martha J Larsen1, Val J Watts2.   

Abstract

Heterologous sensitization of adenylyl cyclase (AC) is revealed as enhanced or exaggerated AC/cAMP signaling that occurs following persistent activation of Gα i/o-coupled receptors. This paradoxical phenomenon was discovered more than 40 years ago and was proposed as a cellular mechanism to explain the adaptive changes that occur following chronic exposure to drugs of abuse. However, the underlying molecular mechanisms of heterologous sensitization of AC remain largely unknown. In the present study, we performed a genome-wide cell-based RNA interference screen as an unbiased approach to identify genes associated with heterologous sensitization of AC. Following a series of validation and confirmation assays, three genes that form an E3 ligase complex, cullin3 (CUL3), neural precursor-cell-expressed and developmentally downregulated 8 (NEDD8), and really interesting new gene (RING)-box protein 1 (RBX1), were identified as specific modulators of heterologous sensitization of AC. Furthermore, based on the downstream actions of these genes, we evaluated the activity of proteasome inhibitors as well as the specific NEDD8-activating enzyme inhibitor, MLN4924 (Pevonedistat), in AC sensitization. We demonstrate that MG-132 and bortezomib treatments could mimic the inhibitory effects observed with gene knockdown, and MLN4924 was potent and efficacious in blocking the development of heterologous sensitization of endogenous and recombinant AC isoforms, including AC1, AC2, AC5, and AC6. Together, by using genetic and pharmacological approaches, we identified, for the first time, cullin3-RING ligases and the protein degradation pathway as essential modulators for heterologous sensitization of AC. SIGNIFICANCE STATEMENT: Through a genome-wide cell-based RNA interference screening, we identified three genes that form an E3 ligase complex, cullin3, neural precursor-cell-expressed and developmentally downregulated 8 (NEDD8), and really interesting new gene-box protein 1, as specific modulators of heterologous sensitization of AC. The effect of cullin3, NEDD8, or really interesting new gene-box protein 1 small interfering RNAs on heterologous sensitization was recapitulated by proteasome inhibitors, MG132 and bortezomib, and the specific NEDD8-activating enzyme inhibitor, MLN4924. These results suggest a novel hypothesis in which protein degradation is involved in the sensitization of AC signaling that occurs following chronic activation of Gαi/o-coupled receptors.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31857349      PMCID: PMC7011112          DOI: 10.1124/jpet.119.261255

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  36 in total

1.  ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity.

Authors:  T Ohta; J J Michel; A J Schottelius; Y Xiong
Journal:  Mol Cell       Date:  1999-04       Impact factor: 17.970

2.  Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors.

Authors:  Gabriella Aloisi; Elena Silvano; Mario Rossi; Mark J Millan; Roberto Maggio
Journal:  Neuropharmacology       Date:  2010-10-28       Impact factor: 5.250

3.  Identification of substrates for F-box proteins.

Authors:  Jianping Jin; Xiaolu L Ang; Takahiro Shirogane; J Wade Harper
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

4.  Repeated quinpirole treatments produce neurochemical sensitization and associated behavioral changes in female hamsters.

Authors:  Julia A Chester; Amanda J Mullins; Chau H Nguyen; Val J Watts; Robert L Meisel
Journal:  Psychopharmacology (Berl)       Date:  2006-07-19       Impact factor: 4.530

5.  Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924.

Authors:  Hua Liao; Xiaozhen J Liu; Jonathan L Blank; David C Bouck; Hugues Bernard; Khristofer Garcia; Eric S Lightcap
Journal:  Mol Cell Proteomics       Date:  2011-08-26       Impact factor: 5.911

6.  Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.

Authors:  V J Watts; K A Neve
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

Review 7.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

8.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  Dopamine D(2) Receptor-Mediated Heterologous Sensitization of AC5 Requires Signalosome Assembly.

Authors:  Karin F K Ejendal; Carmen W Dessauer; Terence E Hébert; Val J Watts
Journal:  J Signal Transduct       Date:  2012-03-12

10.  Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine.

Authors:  Li-Min Mao; Wei Wang; Xiang-Ping Chu; Guo-Chi Zhang; Xian-Yu Liu; Yuan-Jian Yang; Michelle Haines; Christopher J Papasian; Eugene E Fibuch; Shilpa Buch; Jian-Guo Chen; John Q Wang
Journal:  Nat Neurosci       Date:  2009-04-06       Impact factor: 24.884

View more
  1 in total

1.  The CUL3/neddylation inhibitor MLN4924 reduces ethanol-induced locomotor sensitization and inflammatory pain allodynia in mice.

Authors:  Zhong Ding; Gregory T Knipp; Richard M van Rijn; Julia A Chester; Val J Watts
Journal:  Behav Brain Res       Date:  2020-12-03       Impact factor: 3.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.